Patent details

Basic Information

Publication number:

EP2024390

PCT Application Number:

PCT/EP/2007/054439

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP077288926

PCT Publication Number:

WO/2007/128815

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

INSULIN DERIVATIVE

French Title of Invention:

DÉRIVÉ INSULINIQUE

German Title of Invention:

INSULINDERIVATE

SPC Number:

Dates

Filing date:

08/05/2007

Grant date:

19/08/2015

EP Publication Date:

19/08/2015

PCT Publication Date:

15/11/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/02/2009

EP B1 Publication Date:

19/08/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/05/2016

Expiration date:

08/05/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/05/2007

 

 

Name:

Novo Nordisk A/S

Address:

-, 2880 Bagsværd, Denmark (DK)

Inventor

1

Name:

KODRA Janos Tibor

Address:

Denmark (DK)

2

Name:

JONASSEN Ib

Address:

Denmark (DK)

3

Name:

GARIBAY Patrick William

Address:

Denmark (DK)

Priority

1

Priority Number:

06113711

Priority Date:

09/05/2006

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

06118254

Priority Date:

01/08/2006

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 38/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages